BlackRock Amends Integra LifeSciences Stake to 8.6%
Ticker: IART · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 917520
| Field | Detail |
|---|---|
| Company | Integra Lifesciences Holdings Corp (IART) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock trimmed its stake in Integra LifeSciences to 8.6%.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating a change in its ownership stake in Integra LifeSciences Holdings Corp. As of December 31, 2023, BlackRock reported beneficial ownership of 7,046,750 shares of Integra LifeSciences' Common Stock, representing 8.6% of the company. This is an amendment (No. 15) to their previous filings, showing a slight decrease from their prior reported stake. This matters to investors because BlackRock is a major institutional investor, and changes in their holdings can signal their confidence (or lack thereof) in the company's future prospects.
Why It Matters
This filing shows BlackRock, a major institutional investor, has adjusted its position in Integra LifeSciences, which can influence market perception and other investors' decisions.
Risk Assessment
Risk Level: low — A minor adjustment by a large institutional investor typically poses low risk to the company's fundamentals.
Analyst Insight
Investors should note BlackRock's minor adjustment but consider it within the context of their overall portfolio and Integra LifeSciences' fundamental performance, rather than as a strong buy/sell signal.
Key Numbers
- 7,046,750 — Shares Beneficially Owned (BlackRock's total shares in Integra LifeSciences as of December 31, 2023)
- 8.6% — Ownership Percentage (BlackRock's percentage of Integra LifeSciences' common stock)
- 15 — Amendment Number (This is the 15th amendment to BlackRock's Schedule 13G filing for Integra LifeSciences)
Key Players & Entities
- BlackRock Inc. (company) — filer and institutional investor
- Integra LifeSciences Holdings Corp (company) — subject company whose shares are being reported
- 7,046,750 (dollar_amount) — number of shares beneficially owned by BlackRock
- 8.6% (dollar_amount) — percentage of Integra LifeSciences' common stock owned by BlackRock
- December 31, 2023 (dollar_amount) — date of the event requiring the filing
- January 25, 2024 (dollar_amount) — date the SC 13G/A was filed
Forward-Looking Statements
- Other institutional investors may review BlackRock's adjusted stake and potentially re-evaluate their own positions in Integra LifeSciences. (Integra LifeSciences Holdings Corp) — medium confidence, target: Q1 2024
- The slight reduction in BlackRock's stake will likely have a minimal direct impact on Integra LifeSciences' stock price. (Integra LifeSciences Holdings Corp) — high confidence, target: near-term
FAQ
What is the purpose of this SC 13G/A filing?
This SC 13G/A filing is an amendment (No. 15) by BlackRock Inc. to report a change in its beneficial ownership of Common Stock in Integra LifeSciences Holdings Corp, as required by Rule 13d-1(b) of the Securities Exchange Act of 1934.
Who is the filer of this document and who is the subject company?
The filer is BlackRock Inc., and the subject company is Integra LifeSciences Holdings Corp. BlackRock is reporting its ownership stake in Integra LifeSciences.
As of what date did the event requiring this filing occur?
The event requiring this filing occurred on December 31, 2023, which is the date for which the ownership data is being reported.
How many shares of Integra LifeSciences does BlackRock Inc. beneficially own, and what percentage does this represent?
As of December 31, 2023, BlackRock Inc. beneficially owns 7,046,750 shares of Integra LifeSciences Holdings Corp. Common Stock, which represents 8.6% of the class.
What rule under the Securities Exchange Act of 1934 is this Schedule 13G filed under?
This Schedule 13G is filed under Rule 13d-1(b) of the Securities Exchange Act of 1934, as indicated by the 'X' in the appropriate box on the cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding INTEGRA LIFESCIENCES HOLDINGS CORP (IART).